BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 59 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $200 | -98.1% | 1,000 | -80.7% | 0.00% | – |
Q2 2023 | $10,669 | -33.4% | 5,179 | +6.7% | 0.00% | – |
Q1 2023 | $16,012 | +67.4% | 4,852 | -16.8% | 0.00% | – |
Q4 2022 | $9,563 | -58.4% | 5,831 | +7.9% | 0.00% | – |
Q3 2022 | $23,000 | +9.5% | 5,404 | -29.0% | 0.00% | – |
Q2 2022 | $21,000 | -12.5% | 7,611 | +5.4% | 0.00% | – |
Q1 2022 | $24,000 | +100.0% | 7,222 | +133.6% | 0.00% | – |
Q4 2021 | $12,000 | -68.4% | 3,092 | -73.6% | 0.00% | – |
Q3 2021 | $38,000 | -72.5% | 11,727 | -67.7% | 0.00% | – |
Q2 2021 | $138,000 | -25.0% | 36,316 | -24.0% | 0.00% | – |
Q1 2021 | $184,000 | -13.6% | 47,780 | +1.9% | 0.00% | – |
Q4 2020 | $213,000 | -67.4% | 46,869 | +21.3% | 0.00% | – |
Q3 2020 | $654,000 | -8.9% | 38,636 | -39.7% | 0.00% | – |
Q2 2020 | $718,000 | +227.9% | 64,025 | +36.3% | 0.00% | – |
Q1 2020 | $219,000 | +123.5% | 46,966 | +104.3% | 0.00% | – |
Q4 2019 | $98,000 | +19.5% | 22,991 | +9.5% | 0.00% | – |
Q3 2019 | $82,000 | -1.2% | 21,000 | 0.0% | 0.00% | – |
Q2 2019 | $83,000 | -8.8% | 21,000 | 0.0% | 0.00% | – |
Q1 2019 | $91,000 | +28.2% | 21,000 | +5.0% | 0.00% | – |
Q4 2018 | $71,000 | -6.6% | 20,000 | 0.0% | 0.00% | – |
Q3 2018 | $76,000 | -2.6% | 20,000 | 0.0% | 0.00% | – |
Q2 2018 | $78,000 | +66.0% | 20,000 | +33.3% | 0.00% | – |
Q1 2018 | $47,000 | -20.3% | 15,000 | 0.0% | 0.00% | – |
Q4 2017 | $59,000 | -4.8% | 15,000 | -0.4% | 0.00% | – |
Q3 2017 | $62,000 | 0.0% | 15,064 | +0.4% | 0.00% | – |
Q2 2017 | $62,000 | -3.1% | 15,000 | 0.0% | 0.00% | – |
Q1 2017 | $64,000 | +68.4% | 15,000 | 0.0% | 0.00% | – |
Q4 2016 | $38,000 | +58.3% | 15,000 | +47.1% | 0.00% | – |
Q3 2016 | $24,000 | 0.0% | 10,195 | +1.4% | 0.00% | – |
Q2 2016 | $24,000 | -86.5% | 10,053 | -76.8% | 0.00% | – |
Q3 2014 | $178,000 | – | 43,332 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABNER HERRMAN & BROCK LLC | 241,500 | $1,093,000 | 0.17% |
OCCUDO QUANTITATIVE STRATEGIES LP | 90,584 | $410,000 | 0.13% |
EPIQ PARTNERS, LLC | 10,550 | $48,000 | 0.03% |
Phoenix Holdings Ltd. | 173,683 | $799,000 | 0.02% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 5,500 | $25,000 | 0.02% |
CFO4Life Group, LLC | 12,003 | $54,000 | 0.02% |
HighPoint Advisor Group LLC | 15,733 | $115,000 | 0.01% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 357,761 | $1,619,000 | 0.01% |
Virtu Financial LLC | 24,484 | $111,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 93,902 | $435,000 | 0.01% |